Research and Development Expense (Annual) Chart

Historical Research and Development Expense (Annual) Data

View and export this data back to 1994. Start Trial.
Date Value
December 31, 2024 0.749M
December 31, 2023 1.144M
December 31, 2022 1.326M
December 31, 2021 1.13M
December 31, 2020 1.28M
December 31, 2019 1.567M
December 31, 2018 1.551M
December 31, 2017 1.357M
December 31, 2016 1.415M
December 31, 2015 1.632M
December 31, 2014 1.348M
December 31, 2013 0.8251M
December 31, 2012 0.8255M
December 31, 2011 0.6074M
December 31, 2010 0.4814M
December 31, 2009 0.4674M
Date Value
December 31, 2008 0.4746M
December 31, 2007 0.489M
December 31, 2006 0.4445M
December 31, 2005 0.3358M
December 31, 2004 0.3294M
December 31, 2003 0.306M
December 31, 2002 0.358M
December 31, 2001 0.6082M
December 31, 2000 0.4757M
December 31, 1999 0.5262M
December 31, 1998 0.4999M
December 31, 1997 0.4376M
December 31, 1996 0.4137M
December 31, 1995 0.4364M
December 31, 1994 0.4063M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Quest Diagnostics, Inc. --
Labcorp Holdings, Inc. --
OPKO Health, Inc. 124.03M
NeoGenomics, Inc. 37.08M
First Choice Healthcare Solutions, Inc. --